Lexington, MA (October 6, 2008) – Concert Pharmaceuticals, Inc. today announced that Steven B. Bernitz has joined the company as its Senior Vice President and Chief Business Officer. In this role, he will be a member of Concert’s executive management team, designing and implementing strategic planning initiatives and having overall responsibility for Concert’s business development activities. Mr. Bernitz replaces Jeffrey Williams who now serves as a consultant to the company.

Funds will accelerate path to commercialization

BOSTON, MA – October 7, 2008: Mascoma Corporation, with the U.S. Department of Energy (DOE), Michigan Governor Jennifer M. Granholm, members of the Michigan Congressional delegation and the Michigan Economic Development Corporation, today announced that Mascoma has received a total of $26.0 million in funding from the DOE and an overall contribution of $23.5 million from the State of Michigan.

SOUTH SAN FRANCISCO, Calif., Oct. 8 /PRNewswire/ -- LS9, Inc., the
Renewable Petroleum Company(TM), today announces it has appointed Bill
Haywood as Chief Executive Officer. Mr. Haywood brings over 30 years of
experience in the fuels manufacturing business and a proven track record of
planning, engineering, execution and start-up of major projects within the
energy sector.

"The coming year will be pivotal to LS9 as the company delivers
significant achievements in the development of second-generation biofuels,"

Strategic Partnership with In-Q-Tel Brings Portable, Laboratory-Quality Diagnostics to the U.S. Intelligence Community

Industry Leader Stan Lapidus Joins Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced that it has raised $10.8 million in a Series B financing. Proceeds from the financing will be used to accelerate the development of T2 Biosystems’ revolutionary rapid diagnostic platform.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance (MR) technology, today announced the appointment of Pamela J. Weagraff, RAC to the newly created position of Vice President, Regulatory and Quality.

Former Surface Logix CEO, Jim Mahoney, Joins to Spearhead Growth

Shepard Brings More than 25 Years of Specialty Chemical and Polymer Industry Experience to Novomer

Findings Presented at ICAAC/IDSA

CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Quanterix Corporation, the leader in single molecule detection, announced today that Robert Corn, Ph.D. has joined its Scientific Advisory Board (SAB). Dr. Corn is a Professor in the Departments of Chemistry and Biomedical Engineering at the University of California, Irvine. Dr. Corn's primary research areas include the development of new methods for detecting binding of biomolecules to surfaces and chemical modification strategies to control specific and non-specific adsorption of biopolymers to a variety of surfaces.